NAKA director granted 112,781 RSUs vesting Aug 15, 2026

Kindly MD, Inc. (NAKA) director Gregory Elias Xethalis was reported as the sole reporting person on a Form 4 disclosing an award of 112,781 restricted stock units (RSUs) on 09/22/2025.

Rhea-AI Filing Summary

Kindly MD, Inc. (NAKA) director Gregory Elias Xethalis was reported as the sole reporting person on a Form 4 disclosing an award of 112,781 restricted stock units (RSUs) on 09/22/2025. The RSUs are non‑cash, granted at $0 price and are scheduled to vest on August 15, 2026, subject to his continued service on the board through the vesting date. After the reported transaction the filing shows 112,781 shares beneficially owned by the reporting person. The Form is signed by an attorney‑in‑fact on behalf of the reporting person on 09/24/2025.

Positive

• Director equity alignment: Grant of 112,781 RSUs aligns the director's interests with shareholders through equity compensation
• Clear vesting condition and date: RSUs explicitly vest on August 15, 2026 subject to continued board service

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: A director received 112,781 RSUs that vest with continued board service, a routine director compensation event.

The grant of 112,781 restricted stock units to a director at no cash price for the recipient is a common form of equity compensation aligning director incentives with shareholders. Vesting is time‑based (August 15, 2026) and conditioned on continued board service through the vesting date, as explicitly stated in the filing. The disclosure shows direct beneficial ownership of 112,781 shares following the award. The Form 4 filing was executed by an attorney‑in‑fact and contains no additional derivative transactions or other changes in ownership reported.

Securities Analyst

TL;DR: Filing reports a single non‑derivative equity grant to a director; no sales, purchases, or exercises reported.

The Form 4 lists only an acquisition code (A) for Common Stock representing restricted stock units that vest on a specified future date. The reported price is $0 and there are no derivative securities or other transaction types disclosed on this form. All details in the filing are limited to the director grant and the vesting condition tied to continued service; no additional financial metrics or company performance data are included in the document.

Insider Trade Summary

Grant/Award: 112,781 shares

Grant/Award 1 txn

Insider Xethalis Gregory Elias

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	112,781	$0.00	$0.00

Holdings After Transaction: Common Stock — 112,781 shares (Direct)

Footnotes (1)

1. F1. This reflects restricted stock units ("RSUs") that vest on August 15, 2026 (the "Vesting Date"), subject to the reporting person's continued services on the board of directors of the issuer through the Vesting Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 4 filed for NAKA disclose?

The Form 4 discloses that director Gregory Elias Xethalis was granted 112,781 RSUs on 09/22/2025, vesting on August 15, 2026, at a reported price of $0.

Does the Form 4 show any sales or purchases of NAKA shares by the director?

No. The Form 4 reports an acquisition (code A) of RSUs only; there are no sales, dispositions, or option exercises reported.

When do the RSUs reported on the Form 4 vest?

The RSUs are scheduled to vest on August 15, 2026, subject to the reporting person's continued service on the board through that date.

How many NAKA shares does the reporting person beneficially own after the transaction?

The filing shows 112,781 shares beneficially owned following the reported transaction.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Kyle Simon, as attorney‑in‑fact for the reporting person on 09/24/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/24/2025 - 05:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Xethalis Gregory Elias

(Last) (First) (Middle)

5097 SOUTH 900 EAST, SUITE 100

(Street)

SALT LAKE CITY UT 84117

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2025		A		112,781(1)	A	$0	112,781	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This reflects restricted stock units ("RSUs") that vest on August 15, 2026 (the "Vesting Date"), subject to the reporting person's continued services on the board of directors of the issuer through the Vesting Date.

	/s/ Kyle Simon, as attorney-in-fact	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.